Literature DB >> 8035603

Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.

S Hashimoto1, T Koike, W Tatewaki, Y Seki, N Sato, T Azegami, N Tsukada, H Takahashi, H Kimura, M Ueno.   

Abstract

In contrast to patients with disseminated intravascular coagulation (DIC) due to other causes, patients with acute promyelocytic leukemia (APL) receiving standard cytotoxic chemotherapy can be treated safely with antifibrinolytic drugs for prophylaxis of hemorrhage, without the occurrence of thromboembolic complications. However, such drugs should be used cautiously in APL patients who are receiving all-trans retinoic acid (ATRA) differentiation therapy. We report here a patient with APL who had fatal thromboembolism after receiving ATRA and tranexamic acid therapy.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8035603

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


  13 in total

1.  Use of tranexamic acid for disseminated intravascular coagulation with excessive fibrinolysis associated with aortic dissection in a patient with chronic renal failure.

Authors:  Shun-Ichi Kimura; Jun Odawara; Takatoshi Aoki; Masayuki Yamakura; Masami Takeuchi; Yoshihiko Watanabe; Kosei Matsue
Journal:  Int J Hematol       Date:  2009-04-21       Impact factor: 2.490

2.  Clinical Outcomes Associated with Drug-Drug Interactions of Oral Chemotherapeutic Agents: A Comprehensive Evidence-Based Literature Review.

Authors:  Manvi Sharma; Aisha Vadhariya; Soumya Chikermane; Suma Gopinathan; Mariana Chavez-MacGregor; Sharon H Giordano; Michael L Johnson; Holly M Holmes
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

Review 3.  Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies.

Authors:  Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2020-09-09       Impact factor: 2.490

Review 4.  Acute promyelocytic leukaemia in the all trans retinoic acid era.

Authors:  T G DeLoughery; S H Goodnight
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

5.  Acute promyelocytic leukemia presenting as ischemic stroke in young.

Authors:  Rajan Kapoor; H P Pati; Sanjeev Kumar Gupta; Nitin Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2012-02-01       Impact factor: 0.900

Review 6.  Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.

Authors:  J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

7.  Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis.

Authors:  Mihoko Koseki; Noboru Asada; Hidetaka Uryu; Masami Takeuchi; Hidesaku Asakura; Kosei Matsue
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

8.  Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia.

Authors:  Anna Falanga; Laura Russo; Carmen J Tartari
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-12-21       Impact factor: 2.576

Review 9.  Bleeding Disorders in Primary Fibrinolysis.

Authors:  Massimo Franchini; Marco Zaffanello; Pier Mannuccio Mannucci
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

10.  Fatal Pulmonary Embolism following Achilles Tendon Repair: A Case Report and a Review of the Literature.

Authors:  Asim M Makhdom; Simon Garceau; Ronald Dimentberg
Journal:  Case Rep Orthop       Date:  2013-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.